None.
Eur Rev Med Pharmacol Sci. 2024 Feb;28(3):861. doi: 10.26355/eurrev_202402_35364.
The following articles: - "Long non-coding RNA MNX1-AS1 promoted osteosarcoma proliferation and invasion via inhibiting KISS1" by Y.-X. Zhang, H.-X. Cui, L. Liu, G.-K. Yi, published in Eur Rev Med Pharmacol Sci 2019; 23 (14): 6045-6052-DOI: 10.26355/eurrev_201907_18417-PMID: 31364121 - "Long noncoding RNA ZFAS1 promotes hepatocellular carcinoma proliferation by epigenetically repressing miR-193a-3p", by H.-L. Zhou, Y.-F. Zhou, Z.-T. Feng, published in Eur Rev Med Pharmacol Sci 2019; 23 (22): 9840-9847-DOI: 10.26355/eurrev_201911_19547-PMID: 31799651 Have been retracted by the Editor in Chief for misconduct and data fabrication. In 2020, some concerns have been raised on PubPeer about the reliability of data and image duplication. An investigation conducted by the Jining First People's Hospital, the authors' institution, released on December 17, 2021, and on December 29, 2021, respectively, determined that the authors had engaged in academic misconduct by fabricating the research process. Consequently, the Editor in Chief mistrusts the results presented and has decided to withdraw the articles. The corresponding authors did not respond to journal correspondence about the investigation and retraction of these articles. The Publisher apologizes for any inconvenience this may cause.
“长链非编码 RNA MNX1-AS1 通过抑制 KISS1 促进骨肉瘤的增殖和侵袭”，作者：Y.-X. Zhang、H.-X. Cui、L. Liu、G.-K. Yi，发表于 Eur Rev Med Pharmacol Sci 2019；23（14）：6045-6052-DOI：10.26355/eurrev_201907_18417-PMID：31364121
“长链非编码 RNA ZFAS1 通过表观遗传抑制 miR-193a-3p 促进肝细胞癌增殖”，作者：H.-L. Zhou、Y.-F. Zhou、Z.-T. Feng，发表于 Eur Rev Med Pharmacol Sci 2019；23（22）：9840-9847-DOI：10.26355/eurrev_201911_19547-PMID：31799651
这些文章已被主编因不当行为和数据伪造而撤回。2020 年，PubPeer 上对数据和图像重复的可靠性提出了一些担忧。作者所在机构济宁市第一人民医院于 2021 年 12 月 17 日和 12 月 29 日分别进行了调查，结果确定作者存在伪造研究过程的学术不端行为。因此，主编对呈现的结果表示怀疑，并决定撤回这些文章。相应的作者没有回应期刊关于这些文章的调查和撤回的通信。出版商对由此造成的任何不便表示歉意。
